| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 37085 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 37708 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 97533 | Peak area | HGD | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 118940 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 162253 | Peak area | HGD & PDA | Yes |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 307451 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | 390377 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area | HGD & PDA | yes | |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area | LGD | No | |
| Reversed phase POSITIVE ION MODE | CREATINE (M+H)+ | Peak area | N/A | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|